After the substantial popularity of cannabidiol (CBD) among mainstream users, cannabigerol (CBG) emerged as a valuable alternative, or better yet, supplement to CBD- and THC-based products for recreational and medical use.

As a non-intoxicating cannabinoid, cannabigerol is seeing enhanced attention from users, manufacturers, and researchers. Due to the limelight, our cannabigerol guide answers all your users’ concerns about this new cannabinoid.

What Is Cannabigerol (CBG)?

First found in 1964, cannabigerol (CBG), known as the “mother of all cannabinoids, is an unbelievable compound with tons of therapeutic ability. It is simply one of over 100 cannabinoids found in cannabis. Its acidic kind, cannabigerol acid (CBGA), is the structure of numerous other small cannabinoids.

CBGA is the acidic chemical forerunner of 3 main substances:

• Tetrahydrocannabinolic acid (THCA)
• Cannabidiolic acid (CBDA)
• Cannabichromenic acid (CBCA)

As the cannabis plant develops, a group of enzymes break down CBGA to produce these three main cannabinoids. Type of leftover CBGA can become decarboxylated and transform right into CBG. CBG, on the other hand, is found in trace amounts (less than 1% by dry weight).

Since it is found in low concentration in many cannabis plants, CBG-based natural products are not normally sold compared to THC and CBD products. As the interest in this amazing cannabinoid grows, research is ramping up into its therapeutic effects.

How CBG Works?

CBG interacts with the body’s endocannabinoid system (ECS). The endocannabinoid system is responsible for maintaining the internal homeostasis of several essential organic procedures related to mood, sleep, memory, appetites, reproduction, and immune reactions.

The ECS is made up of a system of cannabinoid receptors found throughout the body: CB1 and CB2 receptors. CB1 receptors are usually found in the nerve system and brain. CB2 receptors are mostly found in the immune system.

Cannabigerol binds to both receptors and intensifies the impacts of anandamide, a neurotransmitter referred to as the “euphoric particle,” which is responsible for affecting motivation, appetite, enjoyment, discomfort, and sleep.

CBG is a CB1 receptor agonist, suggesting it interacts with the receptor and causes a rise in anandamide (AEA) level in the nerves. CBG can also connect with CB2 receptors in the gastrointestinal and immune systems. A study has shown that CBGA can influence 5HT1A-receptors. This receptor is responsible for managing serotonin levels. CBG can be a modest block of the receptor, which can impact the serotonin signalling in the main nervous system. On top of that, CBG has been shown to be an adrenoceptor agonist. This helps in regulating the expression of noradrenaline and adrenaline in the main nerves. Adrenaline and noradrenaline are significant neurotransmitters in the supportive nerve system (SNS).

CBG has the adhering to healing advantages without the psychoactive results of THC.

• Antimicrobial
• Antibacterial
• Anti-inflammatory
• Anticancer